RU2003121358A -
METHOD OF INFLUENCE ON THE OUTLET OF WATERFUL MOISTURE IN PRIMARY OPEN-ANGLE ANGLE GLAUCOM
- Google Patents
METHOD OF INFLUENCE ON THE OUTLET OF WATERFUL MOISTURE IN PRIMARY OPEN-ANGLE ANGLE GLAUCOM
Download PDF
Info
Publication number
RU2003121358A
RU2003121358ARU2003121358/15ARU2003121358ARU2003121358ARU 2003121358 ARU2003121358 ARU 2003121358ARU 2003121358/15 ARU2003121358/15 ARU 2003121358/15ARU 2003121358 ARU2003121358 ARU 2003121358ARU 2003121358 ARU2003121358 ARU 2003121358A
Московский НИИ глазных болезней им. Гельмгольца (RU)
Московский НИИ глазных болезней им. Гельмгольца
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Московский НИИ глазных болезней им. Гельмгольца (RU), Московский НИИ глазных болезней им. ГельмгольцаfiledCriticalМосковский НИИ глазных болезней им. Гельмгольца (RU)
Priority to RU2003121358/15ApriorityCriticalpatent/RU2243749C1/en
Application grantedgrantedCritical
Publication of RU2243749C1publicationCriticalpatent/RU2243749C1/en
Publication of RU2003121358ApublicationCriticalpatent/RU2003121358A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Claims (1)
Способ воздействия на отток водянистой влаги больных первичной открытоугольной глаукомой, отличающийся тем, что сначала вводят путем инстилляций гипотензивное средство, а через 20-30 минут - глазные капли эмоксипина два раза в день, в течение 4-8 недель; через 2-3 месяца курс лечения повторяют.A method of influencing the outflow of aqueous humor of patients with primary open-angle glaucoma, characterized in that the hypotensive agent is first administered by instillation, and after 20-30 minutes - eye drops of emoxipin twice a day, for 4-8 weeks; after 2-3 months, the treatment is repeated.
RU2003121358/15A2003-07-152003-07-15Method for influencing aqueous humor discharge in the cases of primary open angle glaucoma
RU2243749C1
(en)
Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
Use of allylamine derivatives, such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection-associated diseases
USE OF PROPIONYL L-CARNITINE OR ITS PHARMACOLOGICALLY ACCEPTABLE SALTS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF LA PEYRONIE'S DISEASE